AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SULPIRIDE

46 registrations across 7 African markets— 25 active

Markets with SULPIRIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
EQUEMOTE
CAPSULE; ORAL
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
DEVODIL 200
TABLET; ORAL
🇿🇼ZimbabweREMEDICA LTDactiveDec 2027
ESPIRIDE ELIXIR🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedMar 2022
SULRID 50MG COMPRIME BOITE DE 20🇨🇮Côte d'IvoireGENPHARMAMAROCexpiredMar 2022
DOPRID 50
Gélule / 50 mg
🇹🇳TunisiaDORCASexpiredMar 2018
DOGMACARE
Gélule / 50 mg
🇹🇳TunisiaPHARMACAREexpiredDec 2014
DOGMAPRID
Gélule / 50 mg
🇹🇳TunisiaALLIANCE PHARMAexpiredOct 2014
DOGMACARE
Gélule / 50 mg
🇹🇳TunisiaPHARMACAREexpiredOct 2012
DOPRID PER OS
Solution buvable / 5 mg/ml
🇹🇳TunisiaDORCASexpiredJan 2011
DOPRID 100
Solution injectable / 100 mg/2 ml
🇹🇳TunisiaDORCASexpiredJul 2010
DOPRID 100
Solution injectable / 100 mg/2 ml
🇹🇳TunisiaDORCASexpiredJul 2010
SULPIRIL
Gélule / 50 MG
🇹🇳TunisiaOPALIA PHARMAexpiredDec 2006
SINAPRID
Comprimé sécable / 200 mg
🇹🇳TunisiaGALPHARMAexpiredDec 2005
SEDATYL
Solution injectable / 100 mg
🇹🇳TunisiaUNIMEDexpiredOct 2004
DOGMATIL
Solution buvable / 0.5%
🇹🇳TunisiaSANOFI AVENTIS PHARMA TUNISIEexpiredMay 2002
DOGMATIL
Gélule / 50 MG
🇹🇳TunisiaSANOFI AVENTIS PHARMA TUNISIEexpiredApr 2002
SINAPRID
Gélule / 50 mg
🇹🇳TunisiaGALPHARMAexpiredDec 2001
SINAPRID
Solution buvable / 0.5%
🇹🇳TunisiaGALPHARMAexpiredApr 2000
SINAPRID
Gélule / 50 mg
🇹🇳TunisiaGALPHARMAexpiredMar 2000
DOGMATIL
Solution injectable / 100 MG
🇹🇳TunisiaSIPHATexpiredFeb 2000
DOGMATIL
Gélule / 50 MG
🇹🇳TunisiaSIPHATexpiredDec 1999
SULPIRIL
Solution buvable / 0.5%
🇹🇳TunisiaOPALIA PHARMAexpiredMay 1997
DOGMATIL
Solution injectable / 100 MG
🇹🇳TunisiaSIPHATexpiredMar 1993
ENDEPEX🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
SULPIRIDE 50 OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
ESPIRIDE🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
SULPIDAL
GELULE
🇲🇦Moroccoactive
DOGMATIL 50 GELU(2x15) SANOFI-AVENTIS France
gélule 50mg (2x15)
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
DOGMATIL
SOLUTION BUVABLE
🇲🇦Moroccoactive
DOGMATIL
GELULE
🇲🇦Moroccoactive
NEURLEP 50 MG
GELULE
🇲🇦Moroccoactive
NEURLEP 50 MG
GELULE
🇲🇦Moroccoactive
DOGMATIL 50MG GELULE BOITE DE 30🇨🇮Côte d'IvoireNEURAXPHARM FRANCEactive
DOGMATIL
SOLUTION INJECTABLE
🇲🇦Moroccoactive
SULPIRIL
sirop / 0,5 g
🇸🇳SenegalOPALIAactive
SULRID
comprimé / 50 mg
🇸🇳SenegalGENPHARMAactive
SULRID
COMPRIME
🇲🇦Moroccoactive
DOGMATIL
gélule / 200 mg
🇸🇳SenegalNEURAXAPHARMactive
DOGMATIL
gélule / 50 mg
🇸🇳SenegalNEURAXAPHARMactive
DOGMATIL 50 GELU(2x15) SANOFI-AVENTIS France
gélule 50mg (2x15)
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
ALIVIAR
gélule / 50 mg
🇸🇳SenegalIBERSENactive
ALIVIAR
GELULE
🇲🇦Moroccoactive
DOGMATIL
SOLUTION BUVABLE
🇲🇦Moroccoactive
DOGMATIL
gélule / 50 mg
🇸🇳SenegalNEURAXAPHARMactive
DOGMATIL
gélule / 200 mg
🇸🇳SenegalNEURAXAPHARMactive
DOGMATIL
COMPRIME SECABLE
🇲🇦Moroccoactive

SULPIRIDE in Africa — Regulatory Overview

SULPIRIDE is registered across 7 African markets with 46 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal, South Africa and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 46 registrations, 25 (54%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.